Analysis
People
Dan Ressler
Life Sciences & Health Care Leader, Global Risk Advisory
Principal | Deloitte Risk & Financial Advisory
Dan is the Life Sciences and Healthcare leader for Global Risk Advisory. He is also a principal in Deloitte Risk and Financial Advisory’s Life Sciences practice, serving as the US Advisory Life Sciences leader. With nearly 25 years of consulting experience in biopharmaceutical R&D, his experience includes capability strategy, complex delivery program leadership, tech integration, post-merger integration, global operating model design, and internal/external sourcing strategies. He has worked with large global pharmaceutical companies, mid-sized biotechs, academic medical research, and medical device companies.
Latest from Dan Ressler
Related content
Perspectives
2022 Life sciences regulatory outlook
Explore the legislative requirements and operational changes that are impacting life sciences compliance teams going into 2023.
Perspectives
COVID-19 response capabilities for life sciences
COVID-19 has caused life sciences organizations to adjust to supply chain, clinical development, and financial disruptions. Where can you focus your response?